
Cheryl A. Grandinetti, PharmD
Articles by Cheryl A. Grandinetti, PharmD


Pneumonia and influenza together represent the seventh leading cause of death in the United States. Pharmacists can influence care by ensuring that appropriate therapy is initiated quickly and closely monitoring patients.

Tuberculosis remains a major global health concern?it is important for the pharmacist to focus on patient medication adherence to avoid drug resistance.

Pharmacists can improve care of patients with hepatitis B or C through recommendations, monitoring, and education.


Dr. Grandinetti is a senior clinical research pharmacist at the National Cancer Institute, National Institutes of Health, Rockville, Md. The views expressed are those of the author and not those of any government agency.

The views expressed are those of the author and not those of any government agency.
Latest Updated Articles
Inflammatory Bowel DiseasePublished: May 15th 2009 | Updated:
Continuity of Care: Pneumonia: Targeting Treatments and Monitoring the ResponsePublished: November 1st 2008 | Updated:
Treatment Goals for Drug-Resistant TuberculosisPublished: November 1st 2008 | Updated:
Helping Hepatitis Patients Manage Their DiseasePublished: February 1st 2008 | Updated:
Continuity of Care: Treating the Cataract PatientPublished: January 1st 2008 | Updated:
PEP for HIV, Hepatitis B, and Hepatitis C May Reduce RiskPublished: August 1st 2007 | Updated:





